Question:
Interim analysis done after 125 patients? Thats quite a small number and its my assumption that call could come as early as March next year assuming they don't take long to select some sites and patients.
Just from my perspective at least it seems to indicate TEVA thinks MSB's therapy won't work. Or in the alternative they are just being ultra cautious.
Do we have any data/results from P2 and P1 of CHF that people could explain clearly gives us really good hope that p3 will be a success?
Question:Interim analysis done after 125 patients? Thats quite a...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |